185 related articles for article (PubMed ID: 31996211)
21. Pituitary Carcinoma in a Patient with an SDHB Mutation.
Tufton N; Roncaroli F; Hadjidemetriou I; Dang MN; Dénes J; Guasti L; Thom M; Powell M; Baldeweg SE; Fersht N; Korbonits M
Endocr Pathol; 2017 Dec; 28(4):320-325. PubMed ID: 28284009
[TBL] [Abstract][Full Text] [Related]
22. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
23. Associations of cholesteryl ester transfer protein (CETP) gene variants with pituitary adenoma.
Sidaraite A; Liutkeviciene R; Glebauskiene B; Vilkeviciute A; Kriauciuniene L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):189-195. PubMed ID: 31012439
[TBL] [Abstract][Full Text] [Related]
24. Clonality of pituitary tumours: more complicated than initially envisaged?
Clayton RN; Farrell WE
Brain Pathol; 2001 Jul; 11(3):313-27. PubMed ID: 11414474
[TBL] [Abstract][Full Text] [Related]
25. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
[TBL] [Abstract][Full Text] [Related]
26. Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course.
Jia W; Sanders AJ; Jia G; Liu X; Lu R; Jiang WG
Anticancer Res; 2013 Aug; 33(8):3123-31. PubMed ID: 23898069
[TBL] [Abstract][Full Text] [Related]
27. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
28. Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma.
Glebauskiene B; Liutkeviciene R; Vilkeviciute A; Gudinaviciene I; Rocyte A; Simonaviciute D; Mazetyte R; Kriauciuniene L; Zaliuniene D
Biomed Res Int; 2018; 2018():7490585. PubMed ID: 29955610
[TBL] [Abstract][Full Text] [Related]
29. A null cell adenoma of the pituitary detected seven years after removal of a prolactinoma. Recurrence or de novo tumourigenesis?
Watanobe H; Kudo K; Okushima T; Fukita Y; Takebe K
Acta Endocrinol (Copenh); 1991 Dec; 125(6):700-4. PubMed ID: 1789066
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and risk factors for headache associated with non-functioning pituitary adenomas.
Yu B; Ji N; Ma Y; Yang B; Kang P; Luo F
Cephalalgia; 2017 Apr; 37(4):348-355. PubMed ID: 27154998
[TBL] [Abstract][Full Text] [Related]
31. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma.
Sheehan JP; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(5 Suppl):408-14. PubMed ID: 12507066
[TBL] [Abstract][Full Text] [Related]
32. 3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations.
Guerrero-Pérez F; Fajardo C; Torres Vela E; Giménez-Palop O; Lisbona Gil A; Martín T; González N; Díez JJ; Iglesias P; Robledo M; Villabona C
Eur J Intern Med; 2019 Nov; 69():14-19. PubMed ID: 31431315
[TBL] [Abstract][Full Text] [Related]
33. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract][Full Text] [Related]
34. Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?
Glebauskiene B; Liutkeviciene R; Vilkeviciute A; Kriauciuniene L; Jakstiene S; Zlatkute E; Tamosiunas A; Zemaitiene R; Vaitkiene P; Zaliuniene D
Dis Markers; 2017; 2017():5839528. PubMed ID: 28194042
[No Abstract] [Full Text] [Related]
35. Relationships among DNA Index, S-Phase, and invasive behavior in anterior pituitary adenomas. A cytometric study of 61 cases with Feulgen-positive DNA analysis.
Mastronardi L; Guiducci A; Buttaro FM; Cristallini EG; Puzzilli F; Maira G
Surg Neurol; 2001 Jul; 56(1):27-32. PubMed ID: 11546567
[TBL] [Abstract][Full Text] [Related]
36. Genomic instability in pituitary adenomas.
Szymas J; Schluens K; Liebert W; Petersen I
Pituitary; 2002; 5(4):211-9. PubMed ID: 14558668
[TBL] [Abstract][Full Text] [Related]
37. Association of ApoE haplotype with clinical evidence of pituitary adenoma.
Sidaraite A; Vilkeviciute A; Glebauskiene B; Kriauciuniene L; Zaliuniene D; Liutkeviciene R
Gene; 2019 Jul; 706():154-161. PubMed ID: 31054363
[TBL] [Abstract][Full Text] [Related]
38. Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy.
Tudorancea A; François P; Trouillas J; Cottier JP; Girard JJ; Jan M; Gilbert-Dussardier B; Richard S; Lecomte P
Ann Endocrinol (Paris); 2012 Feb; 73(1):37-42. PubMed ID: 22265326
[TBL] [Abstract][Full Text] [Related]
39. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
